BioRestorative Therapies (NASDAQ:BRTX) Announces Earnings Results

BioRestorative Therapies (NASDAQ:BRTX) released its quarterly earnings data on Thursday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07, Zacks reports. The business had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.48 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%.

BioRestorative Therapies Trading Down 1.1 %

Shares of BRTX opened at $1.81 on Friday. BioRestorative Therapies has a 12 month low of $1.03 and a 12 month high of $2.55. The firm has a market cap of $12.53 million, a P/E ratio of -1.18 and a beta of 64.37. The stock’s 50 day moving average is $1.97 and its two-hundred day moving average is $1.72.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.